Development, validity and responsiveness of the Clinical COPD Questionnaire
- PMID: 12773199
- PMCID: PMC156640
- DOI: 10.1186/1477-7525-1-13
Development, validity and responsiveness of the Clinical COPD Questionnaire
Abstract
Background: The new Global Obstructive Lung Disease (GOLD) guidelines advice to focus treatment in Chronic Obstructive Pulmonary Disease (COPD) on improvement of functional state, prevention of disease progression and minimization of symptoms. So far no validated questionnaires are available to measure symptom and functional state in daily clinical practice. The aim of this study was to develop and validate the Clinical COPD Questionnaire (CCQ).
Methods: Qualitative research with patients and clinicians was performed to generate possible items to evaluate clinical COPD control. Thereafter, an item reduction questionnaire was sent to 77 international experts. Sixty-seven experts responded and the 10 most important items, divided into 3 domains (symptoms, functional and mental state) were included in the CCQ (scale: 0 = best, 6 = worst).
Results: Cross-sectional data were collected from 119 subjects (57 COPD, GOLD stage I-III; 18 GOLD stage 0 and 44 (ex)smokers). Cronbach's alpha was high (0.91). The CCQ scores in patients (GOLD 0-III) were significantly higher than in healthy (ex)smokers. Furthermore, significant correlations were found between the CCQ total score and domains of the SF-36 (rho = 0.48 to rho = 0.69) and the SGRQ (rho = 0.67 to rho = 0.72). In patients with COPD, the correlation between the CCQ and FEV1%pred was rho =-0.49. Test-retest reliability was determined in 20 subjects in a 2-week interval (Intra Class Coefficient = 0.94). Thirty-six smokers with and without COPD showed significant improvement in the CCQ after 2 months smoking cessation, indicating the responsiveness of the CCQ.
Conclusion: The CCQ is a self-administered questionnaire specially developed to measure clinical control in patients with COPD. Data support the validity, reliability and responsiveness of this short and easy to administer questionnaire.
Figures


Similar articles
-
Validation of the Clinical COPD questionnaire in Italian language.Health Qual Life Outcomes. 2005 Feb 7;3:9. doi: 10.1186/1477-7525-3-9. Health Qual Life Outcomes. 2005. PMID: 15698477 Free PMC article.
-
Validation of the Clinical COPD Questionnaire in Taiwan.COPD. 2016 Jun;13(3):360-6. doi: 10.3109/15412555.2015.1094456. Epub 2015 Dec 17. COPD. 2016. PMID: 26678264
-
Smoking cessation can improve quality of life among COPD patients: validation of the clinical COPD questionnaire into Greek.BMC Pulm Med. 2011 Feb 25;11:13. doi: 10.1186/1471-2466-11-13. BMC Pulm Med. 2011. PMID: 21352544 Free PMC article.
-
Determinants of Clinical COPD Questionnaire in Patients with COPD: A Cross-Sectional Observational Study.Respiration. 2020;99(7):606-616. doi: 10.1159/000507097. Epub 2020 Jul 13. Respiration. 2020. PMID: 32659763
-
Functional status measures for the COPD patient: A practical categorization.Chron Respir Dis. 2019 Jan-Dec;16:1479973118816464. doi: 10.1177/1479973118816464. Chron Respir Dis. 2019. PMID: 30789020 Free PMC article. Review.
Cited by
-
Detection of chronic obstructive pulmonary disease with deep learning using inspiratory and expiratory chest computed tomography and clinical information.J Thorac Dis. 2024 Sep 30;16(9):6101-6111. doi: 10.21037/jtd-24-367. Epub 2024 Sep 26. J Thorac Dis. 2024. PMID: 39444883 Free PMC article.
-
The effects of reduced nicotine content cigarettes on biomarkers of nicotine and toxicant exposure, smoking behavior and psychiatric symptoms in smokers with mood or anxiety disorders: A double-blind randomized trial.PLoS One. 2022 Nov 2;17(11):e0275522. doi: 10.1371/journal.pone.0275522. eCollection 2022. PLoS One. 2022. PMID: 36322562 Free PMC article. Clinical Trial.
-
Beyond FEV₁ in COPD: a review of patient-reported outcomes and their measurement.Int J Chron Obstruct Pulmon Dis. 2012;7:697-709. doi: 10.2147/COPD.S32675. Epub 2012 Oct 16. Int J Chron Obstruct Pulmon Dis. 2012. PMID: 23093901 Free PMC article. Review.
-
A randomised controlled trial testing a web-based, computer-tailored self-management intervention for people with or at risk for chronic obstructive pulmonary disease: a study protocol.BMC Public Health. 2013 Jun 7;13:557. doi: 10.1186/1471-2458-13-557. BMC Public Health. 2013. PMID: 23742208 Free PMC article. Clinical Trial.
-
Quality of life and adherence to inhaled corticosteroids and tiotropium in COPD are related.Int J Chron Obstruct Pulmon Dis. 2016 Jul 26;11:1679-88. doi: 10.2147/COPD.S107303. eCollection 2016. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 27555758 Free PMC article.
References
-
- Siafakas NM, Vermeire P, Pride NB, Paoletti P, Gibson J, Howard P, Yernault JC, Decramer M, Higenbottam T, Postma DS, Rees J. Optimal assessment and management of chronic obstructive pulmonary disease (COPD): a consensus statement of the European Respiratory Society. Eur Respir J. 1995;8:1398–1420. doi: 10.1183/09031936.95.08081398. - DOI - PubMed
-
- Feenstra TL, van Genugten ML, Hoogenveen RT, Wouters EF, Rutten-van Molken MP. The impact of aging and smoking on the future of chronic obstructive pulmonary disease: a model analysis in the Netherlands. Am J Respir Crit Care Med. 2001;164:590–596. - PubMed
-
- Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of chronic airflow limitation – the St George Respiratory Questionnaire. Am Rev Respir Dis. 1992;145:1321–1327. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical